about
Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndromeCardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.Mechanisms of Autoantibody-Induced Pathology.The Root Extract of Gentiana macrophylla Pall. Alleviates Cardiac Apoptosis in Lupus Prone Mice.Receptor-activating autoantibodies and disease: preeclampsia and beyond.Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapyB Cell in Autoimmune Diseases.Cystamine attenuates lupus-associated apoptosis of ventricular tissue by suppressing both intrinsic and extrinsic pathways.The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.Apheresis in the treatment of idiopathic dilated cardiomyopathy.Iron, oxidative stress, and redox signaling in the cardiovascular system.Down-regulation of microRNA-451a facilitates the activation and proliferation of CD4+ T cells by targeting Myc in patients with dilated cardiomyopathy.Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution.Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy.Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities.Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
P2860
Q24615226-0D38B897-014D-4E1B-A7E8-5E0F1674F766Q33641429-3166447C-321E-4232-8D21-51229EB03E4AQ33740580-33891BBD-3156-44BB-B5B4-1C22913DC54BQ35620319-D4BCAB5F-0387-4E66-A2C3-24D08B154C96Q35707881-2B429C2B-4A8B-441A-AE4F-6C78C1C31DE1Q36647124-0EAD49B2-71BB-42BD-A561-11313E71B50FQ36954468-172318E6-6543-49A7-B0FE-28DCB573B53BQ37294919-1F5CBD18-C0E6-4A69-909F-5B22BC0B5D74Q37826112-4BD38451-A20F-47A5-968F-0276F60C07CEQ37826114-019F5E1A-CC07-4053-9635-C8E89C82484DQ38027456-23503D4F-318C-48EB-BC77-6AFBA53332AEQ38216863-21C479ED-83BF-4669-AD68-DDA2F8D47885Q39100521-48BAE8F8-BF79-480F-8103-DE76DBFCBB06Q39334546-DF1C062D-0564-4233-A695-CD013F673931Q39604148-73CCCC1D-61A7-4502-B3DB-5B59906A7779Q42362111-DDA65BF6-E6CB-412D-8A9B-525C5ED3C24DQ45325142-9BC17DD6-620C-46BE-B1E8-563EC2B99057Q47310813-9FAA0938-CC14-4752-84E6-1EFAC56DDBB2Q47883122-F7DC885A-837C-461C-B4CB-BAFE3BAC8C10
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathological autoantibodies in cardiomyopathy.
@en
Pathological autoantibodies in cardiomyopathy.
@nl
type
label
Pathological autoantibodies in cardiomyopathy.
@en
Pathological autoantibodies in cardiomyopathy.
@nl
prefLabel
Pathological autoantibodies in cardiomyopathy.
@en
Pathological autoantibodies in cardiomyopathy.
@nl
P2093
P2860
P1433
P1476
Pathological autoantibodies in cardiomyopathy
@en
P2093
Georg Ertl
Roland Jahns
Valentin Schwarzbach
Valérie Boivin
P2860
P304
P356
10.1080/08916930802031603
P577
2008-09-01T00:00:00Z